Bangalore, India -- (SBWire) -- 09/07/2017 --United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2017 report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest

with sales (volume), revenue (value), market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs in these regions, from 2012 to 2022 (forecast).

United States Chemotherapy-Induced Nausea and Vomiting Drugs market competition by top manufacturers/players, with Chemotherapy-Induced Nausea and Vomiting Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs for each application, including

Serotonin Receptor Antagonists
NK1 Receptor Antagonists

Spanning over 98 pages "United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2017" report covers Chemotherapy-Induced Nausea and Vomiting Drugs Overview, United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Players/Suppliers, United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017), United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017), United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Volume) by Application (2012-2017), United States Chemotherapy-Induced Nausea and Vomiting Drugs Players/Suppliers Profiles and Sales Data, Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Marketing Strategy Analysis, Distributors/Traders, Market Effect Factors Analysis, United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Value and Volume) Forecast (2017-2022), Research Findings and Conclusion, Appendix.

For more information Visit at: http://www.drugpipeline.net/qyresearch/united-states-chemotherapy-induced-nausea-and-vomiting-drugs-market-report-2017

Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare

Related Reports;

United States Healthcare/Medical Simulation Market Report 2017; visit at - http://www.drugpipeline.net/qyresearch/united-states-healthcaremedical-simulation-market-report-2017

United States Transdermal Scopolamine Market Report 2017; visit at - http://www.drugpipeline.net/qyresearch/united-states-transdermal-scopolamine-market-report-2017

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.